Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Cooper

Showing results (231-240 of 245) with videos related to

Pageof 25
Sort By:
Cancer|February 17, 2001
Social support as a buffer to the psychological impact of stressful life events in women with breast cancerA B Kornblith, J E Herndon, E Zuckerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawalN Dawson, W D Figg, O W Brawley, et al.
Cancer|July 1, 1982
Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology AssociationD V Jackson, B R Paschal, C Ferree, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140H L Parnes, C Cirrincione, J Aisner, et al.
Cancer|December 15, 1981
Intravenous vincristine infusion: phase I trialD V Jackson, V S Sethi, C L Spurr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristicsA Schatzkin, E Lanza, L S Freedman, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 24, 2001
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioningC L Cameron, D Cella, J E Herndon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group BA B Kornblith, J E Herndon, E Zuckerman, et al.
Pageof 25

Showing results (231-240 of 245) with videos related to

Sort By:
Pageof 25
Cancer|February 17, 2001
Social support as a buffer to the psychological impact of stressful life events in women with breast cancerA B Kornblith, J E Herndon, E Zuckerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawalN Dawson, W D Figg, O W Brawley, et al.
Cancer|July 1, 1982
Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology AssociationD V Jackson, B R Paschal, C Ferree, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140H L Parnes, C Cirrincione, J Aisner, et al.
Cancer|December 15, 1981
Intravenous vincristine infusion: phase I trialD V Jackson, V S Sethi, C L Spurr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristicsA Schatzkin, E Lanza, L S Freedman, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 24, 2001
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioningC L Cameron, D Cella, J E Herndon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group BA B Kornblith, J E Herndon, E Zuckerman, et al.
Pageof 25